Navigation Links
SGX Initiates Phase I Trials for SGX523
Date:1/16/2008

than 200 protein kinases and has demonstrated both potent in vitro blockage of the activity of this cancer target and in vivo activity against various types of human cancer cells that depend on cMET for their uncontrolled growth and proliferation. The cMET receptor tyrosine kinase has been implicated in a wide range of cancers, including both solid and blood tumors. cMET has been extensively studied in the laboratory environment and, to a lesser extent, in the clinic, with increasing data suggesting that uncontrolled stimulation of cMET plays a key role in a variety of effects associated with cancer, including cellular growth, increased cell movement and invasion, and an increased ability of cancer cells to metastasize. Other observations have implicated cMET in increased angiogenesis. cMET activation has been observed in a wide range of other cancer types including breast, colon, prostate, pancreatic and gastric cancers.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and cMET tyrosine kinase inhibitors, including SGX523, and JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, the potential of SGX523 as a treatment for certain cancers, the potential outcome of Phase I clinical studies of SGX523, the role of cMET in cancer, statements regarding bringin
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
2. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
3. Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
4. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
5. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
6. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
9. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
10. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
11. Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015   Physicians Rx ... Bernstein has joined the organization as President and ... recently served as President and Chief Executive Officer for ... Chief Executive Officer of Physicians Rx Pharmacy, be responsible ... "We are extremely pleased to bring Gaston on ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and Markets ... "Inhaled Drug Delivery (London, UK - November 19-20, ... Inhaled Drug Delivery meeting will cover industry case studies, ... more. The Co-Chairmen are Dr Steven Nichols , ... Director, Mylan. Companies participating include: ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced the addition of ... 16-18, 2015)" conference to their offering. Regulatory requirements for ... Peru , Brazil , ... , Paraguay , Venezuela , ... Chile This seminar can be viewed both as ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2
... ULURU Inc. (NYSE Amex: ULU ) today ... fourth quarter and year ended 2010 financial results and to provide ... a.m. Eastern Time. To participate in the conference call ... code 23750#) five to ten minutes prior to the initiation of ...
... The Food and Drug Administration (FDA) today approved the use ... of shingles in individuals 50 to 59 years of age. ... of age and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... 200,000 healthy people between the ages of 50 and 59, ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2010 and to Provide a Business Update 2FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age 2
(Date:9/3/2015)... ... ... Local filmmakers and now co-hosts of the up and coming podcast Path11 Podcast ... great success in launching their Path11 Podcast with 23 episodes released since April 2015. ... the well known Spiritual Catalyst and Linda Howe, leader in the field of Akashic ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa can ... professionals out there. His perspective on internal medicine keeps patients happy and healthy, something ... is important regardless of the season, but even more so in the fall, when ...
(Date:9/2/2015)... ... , ... The Aspen Clinic (TAC), located in Basalt, Colorado, today ... inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, Executive Director ... to fitness - we are much more than a gym. Our fitness and ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... University Bloomberg School of Public Health and an internationally recognized scholar on obesity ... for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of Garrison Forest ...
(Date:9/2/2015)... ... September 02, 2015 , ... Chris Harrison of Harrison’s Footwear of ... a simple decision, really,” says Chris. “We have a lot of repeat customers, and ... that work best for them—so we’ve given them the convenience of ordering from home.” ...
Breaking Medicine News(10 mins):Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2
... study says , , TUESDAY, Feb. 12 (HealthDay News) -- Americans ... pain, but new research suggests those extra dollars aren,t buying ... the authors of a study in the Feb. 13 issue ... but the lack of results weren,t. , "This calls into ...
... parent of Northwestern Memorial Hospital, appointed,at its January ... Northwestern,Memorial Foundation,s Boards of Directors., Trina D. ... of the Friends of Prentice,board of directors and ... Committee. Gordon is chairman of Boyden World,Corporation,s board ...
... 12 NHS Choices ( http://www.nhs.uk ),the online ... interactive tool aimed,to help people better understand the ... NHS accredited information, the food allergy symptom checker,( ... whether they have either a food allergy or ...
... The recent influenza,outbreaks across the country, resulting in at ... reminder that the influenza virus is a serious disease,and ... influenza hospitalizes more than 20,000 children,younger than 5 years ... and causes,approximately 100 deaths. These statistics are particularly tragic ...
... Feb. 12 A proposed,regulation to improve the ... by fostering the establishment of Patient Safety Organizations,(PSOs) ... Health and Human,Services (HHS)., PSOs are private ... patient safety events reported by health care providers. ...
... jaw adjustment, BLOOMINGTON, Ind., Feb. 12 A ... Medicine is advocating for the medical,community to provide relief ... sometimes deadly sleep apnea by using a common and ... just amazing that a few millimeters of adjustment, bringing ...
Cached Medicine News:Health News: Back Pain Spending Up, Relief Down 2Health News: Back Pain Spending Up, Relief Down 3Health News:Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors 2Health News:Childhood Influenza Immunization Coalition Responds to Recent Influenza Outbreaks 2Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 2Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 3Health News:New Patient Safety Proposed Regulation Aims to Improve Health Care Quality and Patient Safety 4Health News:Dental Devices Offer a Simple Solution for Sleep 2Health News:Dental Devices Offer a Simple Solution for Sleep 3
... to do the exams you want: ,Four probe ... the easiest water path probe in the industry, ... exactly what you need to. From full ... chamber, the P60 provides the clarity of images ...
... will find the samaritan AED easy ... medical and rescue professionals) will appreciate ... manual override, and the ECG monitoring ... AED is an exceptionally well-engineered, lightweight ...
... extraordinary combination of features make the ... multi-specialty clinical environment. The versatility and ... hardware allows you to perform a ... high-quality results., ,The ideal choice for ...
Assay for Anti-HTLV-I and Anti-HTLV-II...
Medicine Products: